Blalock Williams’s Merck MRK Stock Holding History

Blalock Williams’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	2,106 +150	+8%	+$17.6K	0.18%	119
2026 Q1	$235K	Buy	+1,956	New	+$226K	0.18%	122

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Blalock Williams's MRK Position: Q2 2026 in Review

Blalock Williams increased its Merck (MRK) stake by 7.7% in Q2 2026, buying an estimated $17.6K and bringing the position to 2,106 shares worth $271K. The position accounts for 0.18% of the portfolio, ranked #119.

Blalock Williams first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Blalock Williams held 2,106 shares of Merck worth $271K as of Q2 2026.
Blalock Williams bought 150 Merck shares in Q2 2026, an estimated $17.6K.
Merck made up 0.18% of Blalock Williams's portfolio in Q2 2026, its #119 holding.
Blalock Williams first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Blalock Williams's 13F filing for Q2 2026, filed 7 Aug 2026.